Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation

v3.22.2.2
Stock-based Compensation
9 Months Ended
Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-based Compensation

Note 13 – Stock-based Compensation

 

The Company’s Amended and Restated 2013 Equity Compensation Plan (the “Plan”) provides for the granting of incentive stock options, nonqualified stock options, restricted stock units, performance units, and stock purchase rights. There were no significant modifications to the Plan during the nine months ended September 30, 2022 and 2021.

 

The following table contains information about the Company’s stock plan at September 30, 2022:

 

    Awards
Reserved for
Issuance
    Awards
Issued &
Exercised
    Awards
Available
for Grant
 
2013 Equity Compensation Plan     45,603 *     32,463 **     13,140  

 

* Increased by 8,651 thousand on January 1, 2022, representing 4% of the total number of shares of common stock outstanding on December 31, 2021.
** Includes both restricted stock grants and option grants

 

The Company recognized stock-based compensation expense (options and restricted share grants) in its condensed consolidated statements of operations as follows:

 

   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
    2022     2021     2022     2021  
Research and Development   $ 554     $ 467     $ 1,660     $ 1,411  
General and Administrative     859       594       2,228       1,806  
Total   $ 1,413     $ 1,061     $ 3,888     $ 3,217  

 

As of September 30, 2022, total compensation costs related to unvested awards not yet recognized was approximately $8.1 million and the weighted-average periods over which the awards are expected to be recognized was 2.4 years.

 

 

Stock Options

 

The following table summarizes the activity for Company’ stock options for the nine months ended September 30, 2022:

 

    Stock Options  
Outstanding at December 31, 2021     28,184  
Granted     1,095  
Exercised     (195 )
Forfeited     (165 )
Cancelled     -  
Expired     (1,137 )
Outstanding at September 30, 2022     27,782  

 

Restricted Stock Awards

 

During the nine months ended September 30, 2022 and 2021, the Company granted restricted stock awards for 0 and 8 thousand shares of common stock, respectively. These awards are typically granted to members of the Board of Directors as payment in lieu of cash fees or as payment to a vendor pursuant to a consulting agreement. The Company values restricted stock awards at the fair market value on the date of grant. The Company recorded the value of the 2021 restricted awards as general and administrative expense of $29 thousand and $85 thousand for the three and nine months ended September 30, 2021, respectively. As of September 30, 2022, there was no unrecognized compensation costs related to restricted stock grants.